A phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-am... von Campone, M., Bachelot, T., Penault-Llorca, F., Pallis, A., Agrapart, V., Pierrat, M. J., Poirot, C., Dubois, F., Xuereb, L., Bossard, C. J., Guigal-Stephan, N., Lockhart, B., Andre, F.

Volltext

A randomised control study comparing the Infant Flow Driver with nasal continuous positive airway pressure in preterm infants von Mazzella, M, Bellini, C, Calevo, M G, Campone, F, Massocco, D, Mezzano, P, Zullino, E, Scopesi, F, Arioni, C, Bonacci, W, Serra, G

Volltext

Maternal dietary PUFAs intake and human milk content relationships during the first month of lactation von SCOPESI, F., CIANGHEROTTI, S., LANTIERI, P.B., RISSO, D., BERTINI, I., CAMPONE, F., PEDROTTI, A., BONACCI, W., SERRA, G.

Volltext

A new method for early detection of infants at risk of long-term neuromotor disabilities von Maggi, E., Impagliazzo, M., Minnella, A., Zanardi, N., Izzo, M., Campone, F., Blanchi, I., Tacchino, C., Shimatani, K., Shima, K., Tsuji, T., Giannoni, P., Fato, M.M., Morasso, P., Casadio, M., Ramenghi, L., Moretti, P.

Volltext

Bacteremia in children: a 2-year review of experience with a pediatric blood culture protocol using BacT/Alert standard bottles von Ceccarelli, Roberto, Palmero, Candida, Mantero, Enrico, Campone, Francesco, Russo, Giuseppe, Frulio, Rosanna, Ugolotti, Elisabetta, Belli, Marialuisa, Jannuzzi, Clotilde

Volltext

Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results f... von André, F., Ciruelos, E.M., Juric, D., Loibl, S., Campone, M., Mayer, I.A., Rubovszky, G., Yamashita, T., Kaufman, B., Lu, Y.-S., Inoue, K., Pápai, Z., Takahashi, M., Ghaznawi, F., Mills, D., Kaper, M., Miller, M., Conte, P.F., Iwata, H., Rugo, H.S.

Volltext

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breas... von Hortobagyi, G.N., Stemmer, S.M., Burris, H.A., Yap, Y.S., Sonke, G.S., Paluch-Shimon, S., Campone, M., Petrakova, K., Blackwell, K.L., Winer, E.P., Janni, W., Verma, S., Conte, P., Arteaga, C.L., Cameron, D.A., Mondal, S., Su, F., Miller, M., Elmeliegy, M., Germa, C., O’Shaughnessy, J.

Volltext

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer von Hortobagyi, Gabriel N, Stemmer, Salomon M, Burris, Howard A, Yap, Yoon-Sim, Sonke, Gabe S, Paluch-Shimon, Shani, Campone, Mario, Blackwell, Kimberly L, André, Fabrice, Winer, Eric P, Janni, Wolfgang, Verma, Sunil, Conte, Pierfranco, Arteaga, Carlos L, Cameron, David A, Petrakova, Katarina, Hart, Lowell L, Villanueva, Cristian, Chan, Arlene, Jakobsen, Erik, Nusch, Arnd, Burdaeva, Olga, Grischke, Eva-Maria, Alba, Emilio, Wist, Erik, Marschner, Norbert, Favret, Anne M, Yardley, Denise, Bachelot, Thomas, Tseng, Ling-Ming, Blau, Sibel, Xuan, Fengjuan, Souami, Farida, Miller, Michelle, Germa, Caroline, Hirawat, Samit, O’Shaughnessy, Joyce

Volltext

Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer von Mosele, F., Stefanovska, B., Lusque, A., Tran Dien, A., Garberis, I., Droin, N., Le Tourneau, C., Sablin, M.-P., Lacroix, L., Enrico, D., Miran, I., Jovelet, C., Bièche, I., Soria, J.-C., Bertucci, F., Bonnefoi, H., Campone, M., Dalenc, F., Bachelot, T., Jacquet, A., Jimenez, M., André, F.

Volltext

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer von Swain, Sandra M, Baselga, José, Kim, Sung-Bae, Ro, Jungsil, Semiglazov, Vladimir, Campone, Mario, Ciruelos, Eva, Ferrero, Jean-Marc, Schneeweiss, Andreas, Heeson, Sarah, Clark, Emma, Ross, Graham, Benyunes, Mark C, Cortés, Javier

Volltext

Review: Quality of animal-source foods von Prache, S., Adamiec, C., Astruc, T., Baéza-Campone, E., Bouillot, P.E., Clinquart, A., Feidt, C., Fourat, E., Gautron, J., Girard, A., Guillier, L., Kesse-Guyot, E., Lebret, B., Lefèvre, F., Le Perchec, S., Martin, B., Mirade, P.S., Pierre, F., Raulet, M., Rémond, D., Sans, P., Souchon, I., Donnars, C., Santé-Lhoutellier, V.

Volltext

Interactions between cancer-associated fibroblasts and tumor cells promote MCL-1 dependency in estrogen receptor-positive breast cancers von Louault, K., Bonneaud, T. L, Séveno, C., Gomez-Bougie, P., Nguyen, F., Gautier, F., Bourgeois, N., Loussouarn, D., Kerdraon, O., Barillé-Nion, S., Jézéquel, P., Campone, M., Amiot, M., Juin, P. P., Souazé, F.

Volltext

Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced br... von Rugo, H.S., André, F., Yamashita, T., Cerda, H., Toledano, I., Stemmer, S.M., Jurado, J.C., Juric, D., Mayer, I., Ciruelos, E.M., Iwata, H., Conte, P., Campone, M., Wilke, C., Mills, D., Lteif, A., Miller, M., Gaudenzi, F., Loibl, S.

Volltext

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2 von Piccart, M., Hortobagyi, G.N., Campone, M., Pritchard, K.I., Lebrun, F., Ito, Y., Noguchi, S., Perez, A., Rugo, H.S., Deleu, I., Burris, H.A., Provencher, L., Neven, P., Gnant, M., Shtivelband, M., Wu, C., Fan, J., Feng, W., Taran, T., Baselga, J.

Volltext

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study von Rugo, H.S., O’Shaughnessy, J., Boyle, F., Toi, M., Broom, R., Blancas, I., Gumus, M., Yamashita, T., Im, Y.-H., Rastogi, P., Zagouri, F., Song, C., Campone, M., San Antonio, B., Shahir, A., Hulstijn, M., Brown, J., Zimmermann, A., Wei, R., Johnston, S.R.D., Reinisch, M., Tolaney, S.M.

Volltext

A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer von Delorenzi, Mauro, Farmer, Pierre, Bonnefoi, Hervé, Anderle, Pascale, Cameron, David, Wirapati, Pratyakasha, Becette, Véronique, André, Sylvie, Piccart, Martine, Campone, Mario, Brain, Etienne, MacGrogan, Gaëtan, Petit, Thierry, Jassem, Jacek, Bibeau, Frédéric, Blot, Emmanuel, Bogaerts, Jan, Aguet, Michel, Bergh, Jonas, Iggo, Richard

Volltext

Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macroph... von Gomez-Roca, C.A., Italiano, A., Le Tourneau, C., Cassier, P.A., Toulmonde, M., D’Angelo, S.P., Campone, M., Weber, K.L., Loirat, D., Cannarile, M.A., Jegg, A.-M., Ries, C., Christen, R., Meneses-Lorente, G., Jacob, W., Klaman, I., Ooi, C.-H., Watson, C., Wonde, K., Reis, B., Michielin, F., Rüttinger, D., Delord, J.-P., Blay, J.-Y.

Volltext

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic... von Pierga, J.-Y., Hajage, D., Bachelot, T., Delaloge, S., Brain, E., Campone, M., Diéras, V., Rolland, E., Mignot, L., Mathiot, C., Bidard, F.-C.

Volltext

Use of tamoxifene-controlled ovarian hyperstimulation for fertility preservation before breast cancer treatment: A prospective cohort study with a 5-year follow-up von Dezellus, A., Mirallie, S., Leperlier, F., Sauterey, B., Bouet, P.-E., Dessaint, A., Duros, S., Gremeau, A.S., Mouret-Reynier, M.-A., Durand, L.M., Venat, L., De Blay, P., Robert, M., Freour, T., Campone, M., Blanc-Lapierre, A., Bordes, V.

Volltext

A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast... von Goldstein, Lori J., Mansutti, Mauro, Levy, Christelle, Chang, Jenny C., Henry, Stephanie, Fernandez-Perez, Isaura, Prausovà, Jana, Staroslawska, Elzbieta, Viale, Giuseppe, Butler, Beth, McCanna, Susan, Ruffini, Pier Adelchi, Wicha, Max S., Schott, Anne F.

Volltext